在稳定的COPD患者中,TMPRSS6基因型对铁状况参数的影响
Marko Trtica1, Ivana Novaković2, Violeta Dopsaj1
1University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade.
单核酸多态 rs855791 没有影响COPD患者的铁状况. 然而,小组分析显示了红色素水平的差异,这表明它可能在COPD病变发生过程中发挥作用.
科学领域:
- 遗传学 是一个遗传学.
- 肺部病理学 肺部病理学
- 血液学 血液学 血液学
背景情况:
- 单核酸多态 (SNP) rs855791与肝素水平和铁代谢标志物有关.
- 慢性阻塞性肺病 (COPD) 经常与铁的状态改变和炎症性贫血有关.
研究的目的:
- 为了调查SNP rs855791在COPD患者中的患病率.
- 为了评估这种多形态对稳定的COPD铁状况参数的影响.
主要方法:
- 对29名野生型 (WT) 和65名基因型变体 (HH) COPD患者的铁状况和遗传数据的分析.
- 在192名健康志愿者中评估SNP rs855791频率.
主要成果:
- 在COPD患者和对照人群中,SNP rs855791的患病率相似.
- 在WT和HHCOPD组之间没有发现铁状况参数的显著差异.
- 一个小组分析,不包括维生素B12缺乏或低氧症的患者,在WT组中显示了显著较低的红素 (EPO) 水平.
结论:
- 在稳定的COPD患者中,SNP rs855791似乎没有影响铁的状态.
- 在一个子组中观察到EPO水平的统计学上显著,但不具有临床意义的差异.
- 对于EPO在调节肝素,铁缺乏和COPD炎症方面的潜在作用,需要进一步研究.
更多相关视频
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
